Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Thursday, December 4, 2014 7:28 PM | CCSVI Alliance Volg link
Today, December 4, 2014 is the last day to submit comments to the U.S. Food and Drug Administration (FDA) Docket # FDA-2014-N-1968 ..
"Food and Drug Administration Activities for Patient Participation in Medical Product Discussions; Establishment of a Public Docket"

The Food and Drug Administration (FDA) is announcing the establishment of a public docket for comments on FDA activities performed under the Food and Drug Administration Safety and Innovation Act (FDASIA), Patient Participation in Medical Product Discussions. This notice announces FDA’s intent to gather input from stakeholders on strategies to obtain the views of patients during the medical product development process and ways to consider patients’ perspectives during regulatory discussions.

-- The FDA is asking how the patient wants to be included in the review of devices and drugs in the management of their disease. This is your opportunity to express your unique perspective as a patient. Become part of the process -- no one understands neurological disease better than those who live with it day to day--

Link to the Docket: http://www.regulations.gov/#!documentDetail;D=FDA-2014-N-1698-0001

Link to the Comment Page:http://www.regulations.gov/#!submitComment;D=FDA-2014-N-1698-0001


www.regulations.gov
www.regulations.gov